Company Filing History:
1 out of 1 
1 out of 11 
1 out of 1 Years Active: 2002-2012
Title: Darko Kontrec: Innovator in Chiral Chromatography
Introduction
Darko Kontrec is a notable inventor based in Zagreb, Croatia. He has made significant contributions to the field of chromatography, particularly in the development of chiral stationary phases. With a total of three patents to his name, Kontrec's work has advanced the separation of enantiomers, which is crucial in pharmaceuticals and other chemical applications.
Latest Patents
Kontrec's latest patents include innovative chiral stationary phases for chromatography based on aromatic allyl amines. These new chiral stationary phases (CSPs) are created using chiral selectors that are covalently bound to a solid support. The chiral selectors are derived from enantiomerically pure aromatic amines and 3,5-dinitrobenzoic acid, linked to the support surface through an allylic double bond. This technology allows for the enantioseparation of racemates and enantiomerically enriched compounds. Additionally, he has developed chiral stationary phases based on derivatives of 4-amino-3,5-dinitrobenzoic acid, which include modified chiral groups and spacer groups. These phases are essential for the separation of enantiomers, enhancing the efficiency of high-performance liquid chromatography.
Career Highlights
Throughout his career, Darko Kontrec has worked with reputable organizations, including the Cooperative Research Center Polytech and the Ruđer Bošković Institute. His experience in these institutions has allowed him to refine his expertise in chromatography and contribute to various research projects.
Collaborations
Kontrec has collaborated with notable colleagues such as Vladimir Vinković and Vitomir Sunjić. These partnerships have fostered a collaborative environment that has led to innovative advancements in their respective fields.
Conclusion
Darko Kontrec's contributions to the field of chromatography through his patents and collaborations highlight his role as a significant innovator. His work continues to impact the separation of enantiomers, which is vital for the pharmaceutical industry and beyond.